Literature DB >> 34936124

Roles of the polybasic furin cleavage site of spike protein in SARS-CoV-2 replication, pathogenesis, and host immune responses and vaccination.

Md Golzar Hossain1, Yan-Dong Tang2,3, Sharmin Akter4, Chunfu Zheng2,5.   

Abstract

The polybasic furin cleavage site insertion with four amino acid motifs (PRRA) in spike protein's S1/S2 junction site is important in determining viral infectivity, transmission, and host range. However, there is no review so far explaining the effect of the furin cleavage site of the spike protein on SARS-CoV-2 replication and pathogenesis in the host and immune responses and vaccination. Therefore, here we specifically focused on genomic evolution and properties of the cleavage site of spike protein in the context of SARS-CoV-2 followed by its effect on viral entry, replication, and pathogenesis. We also explored whether the spike protein furin cleavage site affected the host immune responses and SARS-CoV-2 vaccination. This review will help to provide novel insights into the effects of polybasic furin cleavage site on the current COVID-19 pandemic.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  SARS-CoV-2; furin cleavage site; host immune responses; pathogenesis; spike protein; vaccination

Mesh:

Substances:

Year:  2021        PMID: 34936124     DOI: 10.1002/jmv.27539

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  11 in total

1.  Mapping of SARS-CoV-2 spike protein evolution during first and second waves of COVID-19 infections in India.

Authors:  Vijay Rani Rajpal; Shashi Sharma; Avinash Kumar; Samantha Vaishnavi; Apekshita Singh; Deepmala Sehgal; Mughdha Tiwari; Shailendra Goel; Soom Nath Raina
Journal:  Future Virol       Date:  2022-06-03       Impact factor: 3.015

2.  Puerarin: A Potential Therapeutic for SARS-CoV-2 and Hantavirus Co-Infection.

Authors:  Weizheng Liang; Xiushen Li; Hao Wang; Kechao Nie; Qingxue Meng; Junli He; Chunfu Zheng
Journal:  Front Immunol       Date:  2022-05-19       Impact factor: 8.786

3.  Resilience of Spike-Specific Immunity Induced by COVID-19 Vaccines against SARS-CoV-2 Variants.

Authors:  Laura Ballesteros-Sanabria; Hector F Pelaez-Prestel; Alvaro Ras-Carmona; Pedro A Reche
Journal:  Biomedicines       Date:  2022-04-26

4.  Multiple SARS-CoV-2 Variants Exhibit Variable Target Cell Infectivity and Ability to Evade Antibody Neutralization.

Authors:  Haijun Tang; Long Gao; Zhao Wu; Fang Meng; Xin Zhao; Yun Shao; Guocun Hou; Xiaohong Du; F Xiao-Feng Qin
Journal:  Front Immunol       Date:  2022-03-16       Impact factor: 7.561

Review 5.  "Is Omicron mild"? Testing this narrative with the mutational landscape of its three lineages and response to existing vaccines and therapeutic antibodies.

Authors:  Vijay Rani Rajpal; Shashi Sharma; Avinash Kumar; Shweta Chand; Lata Joshi; Atika Chandra; Sadhna Babbar; Shailendra Goel; Soom Nath Raina; Behrouz Shiran
Journal:  J Med Virol       Date:  2022-04-27       Impact factor: 20.693

Review 6.  Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines.

Authors:  Yusha Araf; Fariya Akter; Yan-Dong Tang; Rabeya Fatemi; Md Sorwer Alam Parvez; Chunfu Zheng; Md Golzar Hossain
Journal:  J Med Virol       Date:  2022-01-23       Impact factor: 20.693

Review 7.  Development of antibody resistance in emerging mutant strains of SARS CoV-2: Impediment for COVID-19 vaccines.

Authors:  Narasimha M Beeraka; Olga A Sukocheva; Elena Lukina; Junqi Liu; Ruitai Fan
Journal:  Rev Med Virol       Date:  2022-04-13       Impact factor: 11.043

8.  Evolution of ACE2-independent SARS-CoV-2 infection and mouse adaption after passage in cells expressing human and mouse ACE2.

Authors:  Kexin Yan; Troy Dumenil; Bing Tang; Thuy T Le; Cameron R Bishop; Andreas Suhrbier; Daniel J Rawle
Journal:  Virus Evol       Date:  2022-07-27

Review 9.  Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?

Authors:  Manish Dhawan; AbdulRahman A Saied; Saikat Mitra; Fahad A Alhumaydhi; Talha Bin Emran; Polrat Wilairatana
Journal:  Biomed Pharmacother       Date:  2022-08-15       Impact factor: 7.419

10.  In silico analysis of mutations near S1/S2 cleavage site in SARS-CoV-2 spike protein reveals increased propensity of glycosylation in Omicron strain.

Authors:  Christopher A Beaudoin; Arun P Pandurangan; So Yeon Kim; Samir W Hamaia; Christopher L-H Huang; Tom L Blundell; Sundeep Chaitanya Vedithi; Antony P Jackson
Journal:  J Med Virol       Date:  2022-06-07       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.